✦ LIBER ✦

Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Glimepiride (GLIM) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting

✍ Scribed by Girod, I.; Willis, M.; Johansen, P.; Schroeder, M.; Thompson, G.; Neslusan, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sources of Long-Term Quality Adjusted Li

✍ Willis, M.; Johansen, P.; Schroeder, M.; Thompson, G.; Girod, I.; Neslusan, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Assessment of the Key Drivers of Cost-Ef

✍ Thompson, G.; Willis, M.; Johansen, P.; Neslusan, C.; Schroeder, M.; Girod, I. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB